{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:59:08Z","timestamp":1792900748501,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.canlet.2023.216267","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T21:01:18Z","timestamp":1686603678000},"page":"216267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer"],"prefix":"10.1016","volume":"567","author":[{"given":"Runxian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2023.216267_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2023.216267_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2023.216267_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101055","article-title":"Lipids in the tumor microenvironment: from cancer progression to treatment","volume":"80","author":"Corn","year":"2020","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.canlet.2023.216267_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41589-022-01017-3","article-title":"Lipid metabolism in T cell signaling and function","volume":"18","author":"Lim","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.canlet.2023.216267_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004584","article-title":"Lipid-loaded macrophages as new therapeutic target in cancer","volume":"10","author":"Marelli","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2023.216267_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","article-title":"Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity","volume":"15","author":"Yan","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2023.216267_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.csbj.2018.11.004","article-title":"Fates of CD8+ T cells in tumor microenvironment","volume":"17","author":"Maimela","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.canlet.2023.216267_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.02.018","article-title":"Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response","volume":"54","author":"Levine","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216267_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41587-020-0651-8","article-title":"Single-cell metabolic profiling of human cytotoxic T cells","volume":"39","author":"Hartmann","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2023.216267_bib10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.immuni.2019.09.003","article-title":"Metabolic profiling using stable isotope tracing reveals distinct patterns of glucose utilization by physiologically activated CD8+ T cells","volume":"51","author":"Ma","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216267_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic coordination of T cell quiescence and activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2023.216267_bib12","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/ni.3438","article-title":"Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation","volume":"17","author":"Pollizzi","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2023.216267_bib13","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216267_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41586-022-04849-0","article-title":"cBAF complex components and MYC cooperate early in CD8+ T cell fate","volume":"607","author":"Guo","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2023.216267_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmet.2020.06.010","article-title":"Amino assets: how amino acids support immunity","volume":"32","author":"Kelly","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2023.216267_bib16","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1038\/s41467-021-24619-2","article-title":"Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development","volume":"12","author":"He","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216267_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41556-017-0002-2","article-title":"A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells","volume":"20","author":"Ma","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2023.216267_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00018-020-03581-0","article-title":"Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resistance","volume":"78","author":"Wei","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2023.216267_bib19","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1016\/S1470-2045(16)30406-5","article-title":"Predictive biomarkers for checkpoint inhibitor-based immunotherapy","volume":"17","author":"Gibney","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2023.216267_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12943-023-01731-z","article-title":"Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Pei","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2023.216267_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41421-019-0130-x","article-title":"Global alteration of T-lymphocyte metabolism by PD-L1 checkpoint involves a block of de novo nucleoside phosphate synthesis","volume":"5","author":"Palaskas","year":"2019","journal-title":"Cell Discov."},{"key":"10.1016\/j.canlet.2023.216267_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1158\/2159-8290.CD-20-0569","article-title":"The complex integration of T-cell metabolism and immunotherapy","volume":"11","author":"Madden","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2023.216267_bib23","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","article-title":"Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells","volume":"34","author":"Elia","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2023.216267_bib24","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.abj5104","article-title":"Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function","volume":"377","author":"Notarangelo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.canlet.2023.216267_bib25","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cmet.2022.07.012","article-title":"Carbon source availability drives nutrient utilization in CD8+ T cells","volume":"34","author":"Kaymak","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2023.216267_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.abb2683","article-title":"Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity","volume":"371","author":"Xu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.canlet.2023.216267_bib27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2023.216267_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6314","article-title":"Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2023.216267_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2023.216267_bib30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2023.216267_bib31","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1084\/jem.20171576","article-title":"Cholesterol negatively regulates IL-9-producing CD8+ T cell differentiation and antitumor activity","volume":"215","author":"Ma","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2023.216267_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153247","article-title":"IL-9\/STAT3\/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity","volume":"132","author":"Xiao","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2023.216267_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb2224","article-title":"A structure of human Scap bound to Insig-2 suggests how their interaction is regulated by sterols","volume":"371","author":"Yan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.canlet.2023.216267_bib34","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41551-021-00826-6","article-title":"Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy","volume":"5","author":"Lei","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.canlet.2023.216267_bib35","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cmet.2022.08.007","article-title":"ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes","volume":"34","author":"Lu","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2023.216267_bib36","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.3390\/ijms23169196","article-title":"mTOR: a potential new target in nonalcoholic fatty liver disease","volume":"23","author":"Feng","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2023.216267_bib37","article-title":"Key events in cancer: dysregulation of SREBPs","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2023.216267_bib38","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41423-020-0365-3","article-title":"Enforced PGC-1\u03b1 expression promotes CD8 T cell fitness, memory formation and antitumor immunity","volume":"18","author":"Dumauthioz","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.canlet.2023.216267_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1158\/2326-6066.CIR-19-0702","article-title":"Fatty acid oxidation controls CD8+ tissue-resident memory T-cell survival in gastric adenocarcinoma","volume":"8","author":"Lin","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.canlet.2023.216267_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2023.216267_bib41","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.immuni.2020.03.003","article-title":"Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation","volume":"52","author":"Karagiannis","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216267_bib42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1158\/1078-0432.CCR-21-1535","article-title":"Cholesterol-lowering intervention decreases mTOR complex 2 signaling and enhances antitumor immunity","volume":"28","author":"Wang","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216267_bib43","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cmet.2022.03.013","article-title":"The mitochondrial pyruvate carrier regulates memory T cell differentiation and antitumor function","volume":"34","author":"Wenes","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2023.216267_bib44","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2017.03.012","article-title":"Polycomb repressive complex 2-mediated chromatin repression guides effector CD8+ T cell terminal differentiation and loss of multipotency","volume":"46","author":"Gray","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216267_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41556-019-0440-0","article-title":"Ketogenesis-generated \u03b2-hydroxybutyrate is an epigenetic regulator of CD8+ T-cell memory development","volume":"22","author":"Zhang","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2023.216267_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.canlet.2023.216267_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/imr.12655","article-title":"Fatty acid metabolism in CD8+ T cell memory: challenging current concepts","volume":"283","author":"Raud","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.canlet.2023.216267_bib48","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cmet.2023.02.013","article-title":"Linoleic acid potentiates CD8+ T cell metabolic fitness and antitumor immunity","volume":"35","author":"Nava Lauson","year":"2023","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2023.216267_bib49","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cmet.2020.11.003","article-title":"Dynamic cardiolipin synthesis is required for CD8+ T cell immunity","volume":"32","author":"Corrado","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.canlet.2023.216267_bib50","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2018.02.012","article-title":"Mitochondria-endoplasmic reticulum contact sites function as immunometabolic hubs that orchestrate the rapid recall response of memory CD8+ T cells","volume":"48","author":"Bantug","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216267_bib51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/med.21727","article-title":"Reinvigorating exhausted CD8+ cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy","volume":"41","author":"Hossain","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.canlet.2023.216267_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41423-019-0344-8","article-title":"Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment","volume":"17","author":"Zhao","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.canlet.2023.216267_bib53","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","article-title":"Metabolic and epigenetic regulation of T-cell exhaustion","volume":"2","author":"Franco","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.canlet.2023.216267_bib54","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216267_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216267_bib56","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/2326-6066.CIR-20-0384","article-title":"Pharmacologic screening identifies metabolic vulnerabilities of CD8+ T cells","volume":"9","author":"Drijvers","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.canlet.2023.216267_bib57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12943-019-0988-0","article-title":"MCT-1\/miR-34a\/IL-6\/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer","volume":"18","author":"Weng","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2023.216267_bib58","first-page":"1622","article-title":"Effect of CEACAM-1 knockdown in human colorectal cancer cells","volume":"16","author":"Han","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2023.216267_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.619765","article-title":"TIM-3 and CEACAM1 are prognostic factors in head and neck squamous cell carcinoma","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.canlet.2023.216267_bib60","article-title":"The emerging role of CD8+ tissue resident memory T (trm) cells in antitumor immunity: a unique functional contribution of the CD103 integrin","volume":"9","author":"S","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2023.216267_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004527","article-title":"Cancer stem-like cells evade CD8+CD103+ tumor-resident memory T (TRM) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model","volume":"10","author":"Corgnac","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2023.216267_bib62","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.7150\/thno.44868","article-title":"FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2023.216267_bib63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13046-019-1049-7","article-title":"CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT\/GSK-3\u03b2\/\u03b2-catenin pathway","volume":"38","author":"Pan","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216267_bib64","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T cell differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216267_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba6006","article-title":"Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice","volume":"13","author":"Kalia","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2023.216267_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe3702","article-title":"Inhibitory signaling sustains a distinct early memory CD8+ T cell precursor that is resistant to DNA damage","volume":"6","author":"Johnnidis","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.canlet.2023.216267_bib67","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.20142237","article-title":"Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells","volume":"212","author":"Odorizzi","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2023.216267_bib68","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216267_bib69","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216267_bib70","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2023.216267_bib71","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1158\/1078-0432.CCR-21-3114","article-title":"Circulating immune bioenergetic, metabolic, and genetic signatures predict melanoma patients' response to anti-PD-1 immune checkpoint blockade","volume":"28","author":"Triozzi","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2023.216267_bib72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.immuni.2022.12.001","article-title":"The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer","volume":"56","author":"Chow","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216267_bib73","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216267_bib74","doi-asserted-by":"crossref","first-page":"ra46","DOI":"10.1126\/scisignal.2002796","article-title":"Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation","volume":"5","author":"Patsoukis","year":"2012","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2023.216267_bib75","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2023.216267_bib76","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1073\/pnas.1016791108","article-title":"Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance","volume":"108","author":"Pedicord","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2023.216267_bib77","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cell.2017.08.018","article-title":"Mitochondrial priming by CD28","volume":"171","author":"Klein Geltink","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216267_bib78","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1016\/j.cell.2021.08.020","article-title":"Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors","volume":"184","author":"Burger","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216267_bib79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41591-019-0734-6","article-title":"Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma","volume":"26","author":"Fairfax","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2023.216267_bib80","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/2326-6066.CIR-17-0632","article-title":"GITR agonism enhances cellular metabolism to support CD8+ T-cell proliferation and effector cytokine production in a mouse tumor model","volume":"6","author":"Sabharwal","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.canlet.2023.216267_bib81","first-page":"337","article-title":"An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy","volume":"3","author":"Chan","year":"2022","journal-title":"Nat. Can. (Que.)"},{"key":"10.1016\/j.canlet.2023.216267_bib82","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13058-018-1066-z","article-title":"Statin drugs to reduce breast cancer recurrence and mortality","volume":"20","author":"Beckwitt","year":"2018","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2023.216267_bib83","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2174\/1381612826666200122124116","article-title":"Pharmacological strategies for insulin sensitivity in obesity and cancer: thiazolidinediones and metformin","volume":"26","author":"Biondo","year":"2020","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.canlet.2023.216267_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.canlet.2023.216267_bib85","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1158\/0008-5472.CAN-21-0052","article-title":"PPAR\u03b1 agonist fenofibrate enhances cancer vaccine efficacy","volume":"81","author":"Chekaoui","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216267_bib86","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1158\/0008-5472.CAN-17-3053","article-title":"Activation of peroxisome proliferator-activated receptors \u03b1 and \u03b4 synergizes with inflammatory signals to enhance adoptive cell therapy","volume":"79","author":"Saibil","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216267_bib87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0300891619868287","article-title":"PGC-1\u03b1 activator-induced fatty acid oxidation in tumor-infiltrating CTLs enhances effects of PD-1 blockade therapy in lung cancer","volume":"106","author":"Wan","year":"2020","journal-title":"Tumori"},{"key":"10.1016\/j.canlet.2023.216267_bib88","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-18-0095","article-title":"PPAR-induced fatty acid oxidation in T cells increases the number of tumor-reactive CD8+ T cells and facilitates anti-PD-1 therapy","volume":"6","author":"Chowdhury","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2023.216267_bib89","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq0021","article-title":"Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer","volume":"14","author":"Tanaka","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2023.216267_bib90","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","article-title":"Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis","volume":"9","author":"Carrer","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2023.216267_bib91","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ccell.2020.08.015","article-title":"Cholesterol pathway inhibition induces TGF-\u03b2 signaling to promote basal differentiation in pancreatic cancer","volume":"38","author":"Gabitova-Cornell","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216267_bib92","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002474","article-title":"Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer","volume":"9","author":"Nam","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2023.216267_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113665","article-title":"Single-intraosseous simvastatin injection suppresses cancers via activating CD8+ T cells","volume":"155","author":"Yuan","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2023.216267_bib94","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005940","article-title":"Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models","volume":"11","author":"Kansal","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2023.216267_bib95","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/s41467-021-22967-7","article-title":"Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint","volume":"12","author":"Schmidt","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216267_bib96","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12885-022-09385-8","article-title":"A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study","volume":"22","author":"Takada","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2023.216267_bib97","article-title":"Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR signalling pathway","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2023.216267_bib98","doi-asserted-by":"crossref","DOI":"10.4161\/trns.28263","article-title":"mTOR signaling and transcriptional regulation in T lymphocytes","volume":"5","author":"Zeng","year":"2014","journal-title":"Transcription"},{"key":"10.1016\/j.canlet.2023.216267_bib99","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nature06322","article-title":"mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex","volume":"450","author":"Cunningham","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2023.216267_bib100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcancer.2017.04.015","article-title":"PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux","volume":"48","author":"O'Donnell","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2023.216267_bib101","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/blood.2021011597","article-title":"PI3K\u03b4\/\u03b3 inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity","volume":"139","author":"Funk","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2023.216267_bib102","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.3390\/ijms22105207","article-title":"Inhibition of the PI3K\/mTOR pathway in breast cancer to enhance response to immune checkpoint inhibitors in breast cancer","volume":"22","author":"Yan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2023.216267_bib103","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41467-021-27833-0","article-title":"Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3K\u03b1\/\u03b2\/\u03b4 treatment","volume":"13","author":"Qi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216267_bib104","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002772","article-title":"Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3","volume":"9","author":"Chung","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2023.216267_bib105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5483\/BMBRep.2020.53.10.149","article-title":"A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity","volume":"53","author":"Kim","year":"2020","journal-title":"BMB Rep"},{"key":"10.1016\/j.canlet.2023.216267_bib106","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002954","article-title":"Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2\/mTORC1\/p62 axis in tumor-infiltrating CD8T lymphocytes","volume":"9","author":"Nishida","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.canlet.2023.216267_bib107","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","article-title":"Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity","volume":"33","author":"He","year":"2021","journal-title":"Cell Metabol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523002185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523002185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:11:50Z","timestamp":1759594310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":107,"alternative-id":["S0304383523002185"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216267","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216267"}}